The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Salma K. Jabbour

Honoraria: Novocure (less than $10,000 USD in a single calendar year), syntactx (less than $10,000 USD in a single calendar year), IMX Medical Reviewer (less than $10,000 USD in a single calendar year), Advarra (less than $10,000 USD in a single calendar year), Radialogica ($10,000 USD or above in a single calendar year), Merck (less than $10,000 USD in a single calendar year)

Consulting or Advisory Role: Merck Sharp & Dohme (less than $10,000 USD in a single calendar year), Syntactx (less than $10,000 USD in a single calendar year), IMX Medical Reviewer (less than $10,000 USD in a single calendar year)

Research Funding: Merck Sharp & Dohme (Inst), NCI (Inst), Beigene (Inst), Natera (Inst)

No other potential conflicts of interest were reported.